What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?

Hepatology

Volumn 27, Issue 6, 1998, Pages 1700-1702

  Pawlotsky, Jean Michel ^a   Lonjon, Isabelle ^a   Hezode, Christophe ^a   Raynard, Bruno ^a   Darthuy, Francoise ^a   Remire, Jocelyne ^a   Soussy, Claude James ^a   Dhumeaux, Daniel ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTIBODIES, VIRAL; BLOOD BANKS; BLOOD DONORS; COSTS AND COST ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 0031749658     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270632     Document Type: Article

References (12)

1. Weiner AJ, Truett MA, Rosenblatt J, Han J, Quan S, Polito A, Kuo G, et al. HCV testing in low-risk population. Lancet 1990;336:695.
2. Lok ASF, Ma OCK, Chan TM, Lai CL, Chung HT, Ng CPL, Lam JSC. Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera. HEPATOLOGY 1991;14:756-762.
3. Alter HJ. New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus. HEPATOLOGY 1992;15:350-353.
4. Chaudary RK, McLean C. Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay. Am J Clin Pathol 1993;99:702-704.
5. Farci P, London WT, Wong DC, Dawson GJ, Vallari DS, Engle R, Purcell RH. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first-and second-generation assays and relationship to HCV viremia. J Infect Dis 1992;165:1006-1011.
6. Huber KR, Sebesta C, Bauer K. Detection of common hepatitis C virus subtypes with a third-generation enzyme immunoassay. HEPATOLOGY 1996;24:471-473.
7. van der Poel CL, Cuypers HIM, Reesink HW, Weiner AJ, Quan S, diNello R, van Boven JJP, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991;337:317-319.
8. Pawlotsky JM. Significance of indeterminate second-generation RIBA and resolution by third-generation RIBA. In: Groupe Français d'Etudes Moléculaires des Hépatites (GEMHEP), ed. Hepatitis C Virus: New Diagnostic Tools. Paris: John Libbey Eurotext, 1994:17-28.
9. Couroucé AM. Evolution of the successively introduced anti-HCV test kits and their compared performances. In: Ghnassia JC, Harzic M, Maisonneuve P, Noël L, eds. XIe Colloque de Virologie de Versailles-Le Chesnay. Paris: Elsevier, 1997:69-74.
10. Sayers MH, Gretch DR. Recombinant immunoblot and polymerase chain reaction testing in volunteer whole blood donors screened by a multi-antigen assay for hepatitis C virus antibodies. Transfusion 1993;33:809-813.
11. Pawlotsky JM. Chronic hepatitis C virus infection with repeatedly normal aminotransferase levels: disease or not disease? Am J Gastroenterol 1997;92:1775-1777.
12. Dhumeaux D, Doffoël M, Galmiche JP. A French consensus conference on hepatitis C: screening and treatment. J Hepatol 1997;27:941-944.